TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
QIAGEN DNA Synthesis AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
93,514
|
67,221
|
52,430 |
| Financial expenses |
4,806
|
6,005
|
3,315 |
| Earnings before taxes |
-1,692
|
-26,604
|
-35,550 |
| EBITDA |
10,421
|
-13,309
|
-26,878 |
| Total assets |
98,063
|
113,219
|
106,603 |
| Current assets |
48,024
|
58,135
|
60,039 |
| Current liabilities |
75,822
|
88,458
|
93,924 |
| Equity capital |
22,241
|
24,761
|
12,679 |
| - share capital |
130
|
134
|
134 |
| Employees (average) |
90
|
99
|
105 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
22.7%
|
21.9%
|
11.9% |
| Turnover per employee |
1,039
|
679
|
499 |
| Profit as a percentage of turnover |
-1.8%
|
-39.6%
|
-67.8% |
| Return on assets (ROA) |
3.2%
|
-18.2%
|
-30.2% |
| Current ratio |
63.3%
|
65.7%
|
63.9% |
| Return on equity (ROE) |
-7.6%
|
-107.4%
|
-280.4% |
| Change turnover |
28,516
|
14,522
|
-4,736 |
| Change turnover % |
44%
|
28%
|
-8% |
| Chg. No. of employees |
-9
|
-6
|
8 |
| Chg. No. of employees % |
-9%
|
-6%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.